ImQuest CRO HIV Preclinical antiviral anticancer

Contract Research Services

ImQuest BioSciences is a preclinical CRO that provides expert services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. These preclinical research services are part of our ImQuestSUCCESS Platform and include compound screening to define compound efficacy and drug target validation to define the mechanism of action and toxicity of pharmaceutical products.

We provide preclinical services in the following areas:

We specialize in services for the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines. Our Services.

We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in preclinical contract research. As such, we understand that each product and each client is unique and we strive to provide effective solutions. About Us.

Contact Us to request a quote for infectious disease and cancer preclinical services. Connect with us on LinkedIn and Facebook.

What's New

  • Combination Therapy Key to Fighting Bacterial Infections

    Current antibiotic treatments include using one or two drugs to fight an infection, and these treatments are becoming less and less effective as bacteria and other pathogens continue to develop and spread resistance mechanisms against them.

    Blog Articles

Events

  • Preclinical Contract Research Services

    2004-Present
    Frederick, MD

Meet the Team

Guy Pilkington, Ph.D.

Director, Molecular Virology and Hepatitis Research Services

Dr. Pilkington received his Ph.D. in Biochemistry, Molecular and Cellular Biology from the University of Arizona in 2008 working on the mechanisms regulating mRNA

Our Team